(Q34277859)

1 August 2017

5 references

25 April 2019

18 October 2019

20 November 2019

15 December 2019

12 September 2020

Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview (English)

1 reference

mild cognitive impairment

1 August 2017

5 references

25 April 2019

18 October 2019

20 November 2019

15 December 2019

12 September 2020

cognitive dysfunction

4 references

18 October 2019

20 November 2019

15 December 2019

12 September 2020

fluids and secretions

1 reference

18 October 2019

1 reference

20 November 2019

1 reference

15 December 2019

1 reference

12 September 2020

1 reference

Frederic Brosseron

1

1 reference

1 August 2017

Marius Krauthausen

series ordinal

2

1 reference

1 August 2017

Markus Kummer

series ordinal

3

1 reference

1 August 2017

Michael T Heneka

series ordinal

4

1 reference

1 August 2017

25 February 2014

1 reference

1 August 2017

1 October 2014

5 references

25 April 2019

18 October 2019

20 November 2019

15 December 2019

12 September 2020

Molecular Neurobiology

6 references

1 August 2017

25 April 2019

18 October 2019

20 November 2019

15 December 2019

12 September 2020

50

1 reference

1 August 2017

534-544

1 reference

1 August 2017

2

1 reference

Creative Commons Attribution 4.0 International

1 August 2017

start time

25 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s12035-014-8657-1

0 references

cites work

Multiplex cytokine concentration measurement: how much do the medium and handling matter?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Neuroinflammation and synaptic loss

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Study of interleukin-6 production in Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

A meta-analysis of cytokines in Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Contribution of systemic inflammation to chronic neurodegeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Peripheral cytokines and chemokines in Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Systemic inflammation and disease progression in Alzheimer disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Brain-derived neurotrophic factor levels in Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: correlation with cognitive and functional decline

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Historical insights into cytokines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Inflammatory markers and the risk of Alzheimer disease: the Framingham Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

The role of inflammation in Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

The association between delirium and cognitive decline: a review of the empirical literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Intrathecal inflammation precedes development of Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Cerebral pattern of pro- and anti-inflammatory cytokines in dementias

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Chronic stress and age-related increases in the proinflammatory cytokine IL-6

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Alpha-1-antichymotrypsin and oxidative stress in the peripheral blood from patients with probable Alzheimer disease: a short-term longitudinal study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serum cytokine levels in patients with Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Transforming growth factor beta in Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Elevated levels of tumor necrosis factor alpha and mortality in centenarians.

6 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Comparison of seven commercial enzyme-linked immunosorbent assays for the detection of anti-diphtheria toxin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Blood-based protein biomarkers for diagnosis of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Stage-dependent BDNF serum concentrations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Inflammatory markers and cognition in well-functioning African-American and white elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Serum inflammatory proteins and cognitive decline in older persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Increased systemic inflammatory interleukin-1ß and interleukin-6 during agitation as predictors of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Inflammatory markers in Alzheimer's disease and multi-infarct dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Novel systemic markers for patients with Alzheimer disease? - a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Elevation of serum TNF-α levels in mild and moderate Alzheimer patients with daytime sleepiness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Cytokines in Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Systemic immune aberrations in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Increased soluble tumor necrosis factor receptor levels in the serum of elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Acute phase reactants in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Circulating cytokines in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Combination of serum markers related to several mechanisms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer's disease (DAT): lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor rece

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Serum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182618

A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians

28 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8657-1

Increase in circulating levels of monocyte chemoattractant protein-1 with aging

21 January 2018

1 reference

12 December 2020

Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease

1 reference

12 December 2020

Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease

1 reference

12 December 2020

Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response

1 reference

12 December 2020

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia

1 reference

12 December 2020

Chemokines in CSF of Alzheimer's disease patients

1 reference

12 December 2020

Peripheral Inflammatory Response in Alzheimer's Disease and Multiinfarct Dementia

1 reference

12 December 2020

Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease

1 reference

12 December 2020

Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia

1 reference

12 December 2020

Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations

1 reference

12 December 2020

Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia

1 reference

12 December 2020

10.1007/S12035-014-8657-1

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference